Hallim University Medical Center will hold the 13th Hallim-Upsala International Academic Symposium on the 12th of next month
Oct 24, 2024
On November 12, Hallym University Medical Center (Director Kim Yong-sun) will hold the 13th Hallym-Upsala International Academic Symposium' with Uppsala University, a world-renowned Swedish educational institution, at Ilsong Culture Hall of Hallym University Sacred Heart Hospital.
Antibiotic resistance, in which bacteria and viruses become resistant to certain antibiotics, has now emerged as a global problem beyond Korea. As of 2019, the global death toll from antibiotic resistance was 1.3 million, exceeding the death toll from malaria or AIDS. The World Health Organization (WHO) selected antibiotic resistance as one of the top 10 global health priorities in 2019.
Cancer (malignant tumor) was the number one cause of death in South Koreans in 2023. Last year, the number of deaths from cancer was 85,271, accounting for 24% of all deaths. Cancer has been the leading cause of death for Koreans for 40 years since statistics began to be compiled in 1983, and cancer conquest has become a long-standing task in the medical world.
In this situation, the Hallym-Upsala International Academic Symposium seeks to find solutions to the most emerging issues in the medical world, such as antibiotic resistance and cancer, in precision medicine and innovative treatment. To this end, research status and prospects for the latest treatments using cell therapy, Theranomics (a combination of therapy and diagnostics), digital twins, and big data will be introduced.
The symposium will run from 9 a.m. to 5 p.m., and will be divided into four sessions, with 12 lectures and discussions presented by professors from Hallym University Medical Center and Uppsala University. In the first session, Professor Dan Andersson of the Department of Medical Biochemistry and Microbiology, who heads the Uppsala Antibiotic Center, will take the chair and introduce antibiotic resistance problems and advanced solutions to combat them. First, Professor Kim Yong-kyun of the Department of Infectious Diseases at Hallym University Sacred Heart Hospital will give a presentation on the 「Hallym-Upsala International Cooperation Study」, followed by Nikos Fatis-Kavalopoulos, a researcher at the University of Upsala, who will give a lecture on 「Diagnosing the next generation of infectious diseases: detecting personalized antibiotic combinations and heterogeneous resistance」.
The second session will be followed by lectures on customized treatments such as CAR-T, a cell therapy that genetically manipulates the patient's T cells to attack cancer cells. △ Professor Kim Hyung-soo of the Department of Hematologic Oncology at Hanlim University's Gangnam Sacred Heart Hospital 'CAR-T Cell Therapy for Targeting Individual Customized Solid Tumor Antigens' △'Di Yu, a researcher from the Department of Immunology, Genetics, and Pathology at Uppsala University 'evolution of next-generation CAR-T cell therapy' △'Professor Kristel Bergstrom of the Department of Molecular Pharmacology at Uppsala University 'Delivery of Drugs for Precision Medicine: From Theranomics to 3D Printing.
In the third session, precision medicine using big data is the topic. △ Professor Kim Cheol-ho of the Department of Neurology at Hallym University Chuncheon Sacred Heart Hospital 'From Data to Decision Making: Precision Medicine in the Age of Digital Twin' △ Professor Asa Johansson of the Department of Immunology, Genetics, and Pathology at Uppsala University 'Exploration of Molecular Heterogeneity and Estimation of Drug Effects on Complex Diseases Using Large-Scale Molecular and Registry Data' △ Professor Kim Jwa-kyung of the Department of Nephrology at Hallym University Sacred Heart Hospital 'Exploration of Neutrophils and the Front.
In the last fourth session, under the theme of personalized precision medicine in the fields of gastrointestinal and circulatory internal medicine, △ Seok Ki-tae, a professor of gastrointestinal medicine at Hallym University Chuncheon Sacred Heart Hospital, will present 'Precise medicine in the individual-microbial relationship' △ Tove Fall, a professor of molecular mechanics at Uppsala University, will present 'Large-scale microbiota research for personalized heart-metabolic health'.
"The development of treatments using precision medicine and advanced technology is an important task that can conquer numerous diseases and provide patients with a new life," said Kim Yong-sun, head of Hallym University Medical Center. "This symposium with Uppsala University, a world-renowned university, will serve as an opportunity for the two organizations to achieve academic exchanges and cooperation in various fields, marking a major breakthrough in medical development."
Since 2004, Hallym University Medical Center has formed a close medical academic partnership with Columbia University, Cornell University of Medicine, New York Press Vitarian Hospital, George Washington University of Medicine, UCLA (University of California, Los Angeles), Nagoya City University in Japan, Padua University in Nagasaki University, Italy, and University of Uppsala in Sweden to share the latest medical journalism and cooperate for technological development.
The symposium will be recognized with four training scores from the Korean Medical Association and can participate for free after pre-registration. Pre-registration for the symposium will be available on the website of Hallym University Medical Center until November 8.
Antibiotic resistance, in which bacteria and viruses become resistant to certain antibiotics, has now emerged as a global problem beyond Korea. As of 2019, the global death toll from antibiotic resistance was 1.3 million, exceeding the death toll from malaria or AIDS. The World Health Organization (WHO) selected antibiotic resistance as one of the top 10 global health priorities in 2019.
Cancer (malignant tumor) was the number one cause of death in South Koreans in 2023. Last year, the number of deaths from cancer was 85,271, accounting for 24% of all deaths. Cancer has been the leading cause of death for Koreans for 40 years since statistics began to be compiled in 1983, and cancer conquest has become a long-standing task in the medical world.
In this situation, the Hallym-Upsala International Academic Symposium seeks to find solutions to the most emerging issues in the medical world, such as antibiotic resistance and cancer, in precision medicine and innovative treatment. To this end, research status and prospects for the latest treatments using cell therapy, Theranomics (a combination of therapy and diagnostics), digital twins, and big data will be introduced.
The symposium will run from 9 a.m. to 5 p.m., and will be divided into four sessions, with 12 lectures and discussions presented by professors from Hallym University Medical Center and Uppsala University. In the first session, Professor Dan Andersson of the Department of Medical Biochemistry and Microbiology, who heads the Uppsala Antibiotic Center, will take the chair and introduce antibiotic resistance problems and advanced solutions to combat them. First, Professor Kim Yong-kyun of the Department of Infectious Diseases at Hallym University Sacred Heart Hospital will give a presentation on the 「Hallym-Upsala International Cooperation Study」, followed by Nikos Fatis-Kavalopoulos, a researcher at the University of Upsala, who will give a lecture on 「Diagnosing the next generation of infectious diseases: detecting personalized antibiotic combinations and heterogeneous resistance」.
The second session will be followed by lectures on customized treatments such as CAR-T, a cell therapy that genetically manipulates the patient's T cells to attack cancer cells. △ Professor Kim Hyung-soo of the Department of Hematologic Oncology at Hanlim University's Gangnam Sacred Heart Hospital 'CAR-T Cell Therapy for Targeting Individual Customized Solid Tumor Antigens' △'Di Yu, a researcher from the Department of Immunology, Genetics, and Pathology at Uppsala University 'evolution of next-generation CAR-T cell therapy' △'Professor Kristel Bergstrom of the Department of Molecular Pharmacology at Uppsala University 'Delivery of Drugs for Precision Medicine: From Theranomics to 3D Printing.
In the third session, precision medicine using big data is the topic. △ Professor Kim Cheol-ho of the Department of Neurology at Hallym University Chuncheon Sacred Heart Hospital 'From Data to Decision Making: Precision Medicine in the Age of Digital Twin' △ Professor Asa Johansson of the Department of Immunology, Genetics, and Pathology at Uppsala University 'Exploration of Molecular Heterogeneity and Estimation of Drug Effects on Complex Diseases Using Large-Scale Molecular and Registry Data' △ Professor Kim Jwa-kyung of the Department of Nephrology at Hallym University Sacred Heart Hospital 'Exploration of Neutrophils and the Front.
In the last fourth session, under the theme of personalized precision medicine in the fields of gastrointestinal and circulatory internal medicine, △ Seok Ki-tae, a professor of gastrointestinal medicine at Hallym University Chuncheon Sacred Heart Hospital, will present 'Precise medicine in the individual-microbial relationship' △ Tove Fall, a professor of molecular mechanics at Uppsala University, will present 'Large-scale microbiota research for personalized heart-metabolic health'.
"The development of treatments using precision medicine and advanced technology is an important task that can conquer numerous diseases and provide patients with a new life," said Kim Yong-sun, head of Hallym University Medical Center. "This symposium with Uppsala University, a world-renowned university, will serve as an opportunity for the two organizations to achieve academic exchanges and cooperation in various fields, marking a major breakthrough in medical development."
Since 2004, Hallym University Medical Center has formed a close medical academic partnership with Columbia University, Cornell University of Medicine, New York Press Vitarian Hospital, George Washington University of Medicine, UCLA (University of California, Los Angeles), Nagoya City University in Japan, Padua University in Nagasaki University, Italy, and University of Uppsala in Sweden to share the latest medical journalism and cooperate for technological development.
The symposium will be recognized with four training scores from the Korean Medical Association and can participate for free after pre-registration. Pre-registration for the symposium will be available on the website of Hallym University Medical Center until November 8.
|
bellho@sportschosun.com
